Humana Inc. $HUM is Maple Rock Capital Partners Inc.’s 4th Largest Position

Maple Rock Capital Partners Inc. lifted its stake in Humana Inc. (NYSE:HUM) by 82.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 628,251 shares of the insurance provider’s stock after purchasing an additional 283,451 shares during the period. Humana makes up about 5.0% of Maple Rock Capital Partners Inc.’s investment portfolio, making the stock its 4th biggest position. Maple Rock Capital Partners Inc.’s holdings in Humana were worth $249,554,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Beaconlight Capital LLC acquired a new position in Humana during the second quarter worth $3,265,000. Two Sigma Securities LLC acquired a new stake in Humana during the second quarter worth $1,218,000. Northwestern Mutual Wealth Management Co. raised its holdings in Humana by 11.0% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,824 shares of the insurance provider’s stock valued at $1,122,000 after buying an additional 281 shares during the period. Greenleaf Trust raised its stake in shares of Humana by 25.5% in the 2nd quarter. Greenleaf Trust now owns 2,483 shares of the insurance provider’s stock valued at $986,000 after acquiring an additional 505 shares during the period. Finally, Capital Advisors Inc. OK purchased a new stake in Humana in the second quarter valued at approximately $344,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $384.25 on Tuesday. The firm has a market cap of $46.14 billion, a P/E ratio of 36.35, a P/E/G ratio of 2.20 and a beta of 0.72. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The business’s 50-day moving average price is $386.07 and its 200 day moving average price is $290.60. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period in the prior year, the business earned $6.27 EPS. The firm’s revenue was up 26.2% compared to the same quarter last year. On average, equities research analysts expect that Humana Inc. will post 9.12 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on HUM shares. Guggenheim increased their price target on shares of Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Wells Fargo & Company upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $227.00 to $502.00 in a research note on Monday, July 13th. Seaport Research Partners cut Humana to a “neutral” rating in a research report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft started coverage on Humana in a research note on Thursday, July 30th. They issued a “hold” rating for the company. Finally, Bank of America upgraded shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 target price on the stock in a research report on Wednesday, July 29th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $403.91.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.